大动静脉畸形分体积立体定向放射外科的不良放射效应:多中心研究
这项多中心回顾性研究纳入1991至2016年间9个放射外科中心采用分体积立体定向放射外科(VS-SRS)治疗的257例大型脑动静脉畸形(AVM)患者,评估症状性不良放射效应(ARE)。中位随访5.7年,64例(25%)发生ARE,其中19例为永久性;Z轴最大线性尺寸≥3.28 cm与ARE相关,顶叶浅表病变和颞叶深部病变亦与ARE相关。
要点
- VS-SRS治疗大型AVM后症状性ARE总发生率为25%,永久性ARE为19例。
- Z轴最大线性尺寸阈值3.28 cm与ARE相关,敏感度72.5%、特异度58.3%。
- 顶叶浅表病变和颞叶深部病变与ARE相关,体积并非主要预测因素。
核心结论
- 尺寸仍是立体定向放射外科后毒性的主要预测因素,但ARE总体发生率低于基于基线特征的预期,提示分体积照射可能使剂量与尺寸相对分离。
研究设计与样本
- 多中心回顾性综述,纳入9个放射外科中心1991至2016年间采用计划性前瞻分体积方式(间隔3-6个月)治疗的257例大型AVM患者。
主要发现
- 患者接受2-4个总体积阶段,首次SRS时中位年龄33岁,VS-SRS后中位随访5.7年。
- 中位AVM巢总体积23.25 cm3(范围7.7-94.4 cm3),每阶段中位边缘剂量17 Gy(范围12-20 Gy)。
- 64例(25%)发生ARE,其中19例为永久性。
- Z轴最大线性尺寸与毒性相关,阈值长度3.28 cm与ARE相关,敏感度72.5%、特异度58.3%。
- 顶叶浅表病变和颞叶深部病变与ARE相关。
临床怎么用
- 对大型AVM行VS-SRS规划时,应关注Z轴最大线性尺寸及顶叶浅表、颞叶深部病变等ARE相关因素。
局限性
- 本研究为多中心回顾性综述,需进一步评估其他技术以优化结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The optimal treatment paradigm for large arteriovenous malformations (AVMs) is controversial. One approach is volume-staged stereotactic radiosurgery (VS-SRS). The authors previously reported efficacy of VS-SRS for large AVMs in a multiinstitutional cohort; here they focus on risk of symptomatic adverse radiation effects (AREs). METHODS: This is a multicentered retrospective review of patients treated with a planned prospective volume staging approach to stereotactically treat the entire nidus of an AVM, with volume stages separated by intervals of 3-6 months. A total of 9 radiosurgical centers treated 257 patients with VS-SRS between 1991 and 2016. The authors evaluated permanent, transient, and total ARE events that were symptomatic. RESULTS: Patients received 2-4 total volume stages. The median age was 33 years at the time of the first SRS volume stage, and the median follow-up was 5.7 years after VS-SRS. The median total AVM nidus volume was 23.25 cm3 (range 7.7-94.4 cm3), with a median margin dose per stage of 17 Gy (range 12-20 Gy). A total of 64 patients (25%) experienced an ARE, of which 19 were permanent. Rather than volume, maximal linear dimension in the Z (craniocaudal) dimension was associated with toxicity; a threshold length of 3.28 cm was associated with an ARE, with a 72.5% sensitivity and a 58.3% specificity. In addition, parietal lobe involvement for superficial lesions and temporal lobe involvement for deep lesions were associated with an ARE. CONCLUSIONS: Size remains the dominant predictor of toxicity following SRS, but overall rates of AREs were lower than anticipated based on baseline features, suggesting that dose and size were relatively dissociated through volume staging. Further techniques need to be assessed to optimize outcomes.
引用
- Seymour ZA, Chan JW, McDermott MW, et al. Adverse radiation effects in volume-staged radiosurgery for large arteriovenous malformations: a multiinstitutional study. J Neurosurg. 2021. PMID: 34450589. doi:10.3171/2020.12.JNS201866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。